- Home
- SDEV vs ATRA Comparison
SDEV vs ATRA Comparison
Compare SDEV & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SDEV | ATRA |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | 4 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.1M | 38.9M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | SDEV | ATRA |
|---|---|---|
| Price | $1.15 | $7.81 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 744.6K | 70.6K |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.01 | $3.92 |
| 52 Week High | $1.60 | $19.15 |
Technical Indicators
Market Signals| Indicator | SDEV | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 37.02 |
| Support Level | $1.05 | $4.35 |
| Resistance Level | $1.58 | $11.17 |
| Average True Range (ATR) | 0.11 | 0.66 |
| MACD | -0.02 | -0.17 |
| Stochastic Oscillator | 11.63 | 15.01 |
Price Performance
Historical ComparisonAbout SDEV Stablecoin Development Corporation Common Stock
Stablecoin Development Corp is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The Company's initial digital asset focus is the Sky protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, the Company seeks to generate protocol-level economic returns while maintaining rigorous governance and risk management oversight.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).